LeMaitre Vascular (LMAT) Revenue & Revenue Breakdown
LeMaitre Vascular Revenue Highlights
Latest Revenue (Y)
$193.48M
Latest Revenue (Q)
$55.85M
Main Geography (Y)
Americas
LeMaitre Vascular Revenue by Period
LeMaitre Vascular Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $193.48M | 19.69% |
| 2022-12-31 | $161.65M | 4.68% |
| 2021-12-31 | $154.42M | 19.37% |
| 2020-12-31 | $129.37M | 10.35% |
| 2019-12-31 | $117.23M | 11.05% |
| 2018-12-31 | $105.57M | 4.66% |
| 2017-12-31 | $100.87M | 13.14% |
| 2016-12-31 | $89.15M | 13.78% |
| 2015-12-31 | $78.35M | 10.20% |
| 2014-12-31 | $71.10M | 10.14% |
| 2013-12-31 | $64.55M | 13.77% |
| 2012-12-31 | $56.73M | -1.65% |
| 2011-12-31 | $57.69M | 2.90% |
| 2010-12-31 | $56.06M | 10.12% |
| 2009-12-31 | $50.91M | 4.49% |
| 2008-12-31 | $48.72M | 17.55% |
| 2007-12-31 | $41.45M | 19.69% |
| 2006-12-31 | $34.63M | 12.70% |
| 2005-12-31 | $30.73M | 17.35% |
| 2004-12-31 | $26.18M | 26.71% |
| 2003-12-31 | $20.66M | 19.00% |
| 2002-12-31 | $17.36M | 38.36% |
| 2001-12-31 | $12.55M | - |
LeMaitre Vascular generated $193.48M in revenue during NA 2023, up 19.69% compared to the previous quarter, and up 183.28% compared to the same period a year ago.
LeMaitre Vascular Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $55.85M | 4.43% |
| 2024-03-31 | $53.48M | 9.40% |
| 2023-12-31 | $48.88M | 3.10% |
| 2023-09-30 | $47.41M | -5.40% |
| 2023-06-30 | $50.12M | 6.46% |
| 2023-03-31 | $47.08M | 14.95% |
| 2022-12-31 | $40.95M | 4.93% |
| 2022-09-30 | $39.03M | -7.31% |
| 2022-06-30 | $42.11M | 6.44% |
| 2022-03-31 | $39.56M | 0.15% |
| 2021-12-31 | $39.50M | 2.96% |
| 2021-09-30 | $38.37M | -5.66% |
| 2021-06-30 | $40.67M | 13.34% |
| 2021-03-31 | $35.88M | -4.43% |
| 2020-12-31 | $37.55M | 3.11% |
| 2020-09-30 | $36.42M | 46.54% |
| 2020-06-30 | $24.85M | -18.66% |
| 2020-03-31 | $30.55M | 1.26% |
| 2019-12-31 | $30.17M | 3.68% |
| 2019-09-30 | $29.10M | -1.30% |
| 2019-06-30 | $29.48M | 3.53% |
| 2019-03-31 | $28.48M | 0.32% |
| 2018-12-31 | $28.39M | 17.48% |
| 2018-09-30 | $24.16M | -10.57% |
| 2018-06-30 | $27.02M | 3.95% |
| 2018-03-31 | $25.99M | -0.61% |
| 2017-12-31 | $26.15M | 5.36% |
| 2017-09-30 | $24.82M | -3.62% |
| 2017-06-30 | $25.75M | 6.69% |
| 2017-03-31 | $24.14M | 3.65% |
| 2016-12-31 | $23.29M | 0.31% |
| 2016-09-30 | $23.22M | 3.69% |
| 2016-06-30 | $22.39M | 10.52% |
| 2016-03-31 | $20.26M | -1.10% |
| 2015-12-31 | $20.48M | 7.66% |
| 2015-09-30 | $19.02M | -4.38% |
| 2015-06-30 | $19.90M | 5.01% |
| 2015-03-31 | $18.95M | 1.42% |
| 2014-12-31 | $18.68M | 6.74% |
| 2014-09-30 | $17.50M | -3.63% |
| 2014-06-30 | $18.16M | 8.40% |
| 2014-03-31 | $16.75M | -6.49% |
| 2013-12-31 | $17.92M | 17.10% |
| 2013-09-30 | $15.30M | -4.08% |
| 2013-06-30 | $15.95M | 3.70% |
| 2013-03-31 | $15.38M | 3.93% |
| 2012-12-31 | $14.80M | 8.47% |
| 2012-09-30 | $13.64M | -4.99% |
| 2012-06-30 | $14.36M | 3.11% |
| 2012-03-31 | $13.93M | 3.86% |
| 2011-12-31 | $13.41M | -7.92% |
| 2011-09-30 | $14.56M | -3.63% |
| 2011-06-30 | $15.11M | 3.52% |
| 2011-03-31 | $14.60M | 1.16% |
| 2010-12-31 | $14.43M | 5.68% |
| 2010-09-30 | $13.66M | -3.55% |
| 2010-06-30 | $14.16M | 2.48% |
| 2010-03-31 | $13.81M | 1.70% |
| 2009-12-31 | $13.58M | 1.78% |
| 2009-09-30 | $13.35M | 5.67% |
| 2009-06-30 | $12.63M | 11.30% |
| 2009-03-31 | $11.35M | -6.30% |
| 2008-12-31 | $12.11M | 0.73% |
| 2008-09-30 | $12.02M | -5.62% |
| 2008-06-30 | $12.74M | 7.53% |
| 2008-03-31 | $11.85M | 6.69% |
| 2007-12-31 | $11.10M | - |
LeMaitre Vascular generated $55.85M in revenue during Q2 2024, up 4.43% compared to the previous quarter, and up 118.64% compared to the same period a year ago.
LeMaitre Vascular Revenue Breakdown
LeMaitre Vascular Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Americas | $130.31M | $109.44M | $102.27M | $81.47M | $69.36M |
| EMEA | $51.10M | $41.85M | $42.13M | $39.19M | $39.48M |
| Asia Pacific | $12.08M | $10.36M | $10.03M | $8.70M | $8.39M |
LeMaitre Vascular's latest annual revenue breakdown by geography, as of Dec 23: Americas (67.35%), EMEA (26.41%), and Asia Pacific (6.24%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $14.39M | $25.24M | $13.58M | $12.28M | $10.69M | $10.75M | $10.49M | $10.93M | $10.54M | $10.80M | $9.86M | $10.85M | $10.04M | $7.95M | $10.35M | $10.00M | $9.45M | $10.01M | $10.01M | - |
| Asia Pacific | $3.84M | $6.38M | $3.03M | $2.67M | $2.85M | $2.50M | $2.52M | $2.63M | $2.53M | $2.54M | $2.32M | $2.69M | $2.19M | $1.96M | $1.86M | $2.39M | $1.95M | $1.96M | $2.09M | - |
| Americas | $35.24M | $64.67M | $33.51M | $32.13M | $27.41M | $28.85M | $26.54M | $25.94M | $25.30M | $27.33M | $23.70M | $24.01M | $24.18M | $14.94M | $18.34M | $17.77M | $17.70M | $17.51M | $16.38M | - |
| GERMANY | - | - | - | - | - | $2.81M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | - | - | - | - | - | $24.24M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Countries | - | - | - | - | - | $8.74M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| CANADA | - | - | - | - | - | $1.96M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LeMaitre Vascular's latest quarterly revenue breakdown by geography, as of Mar 24: Americas (65.91%), EMEA (26.92%), and Asia Pacific (7.18%).
LeMaitre Vascular Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| NVST | Envista | $2.57B | $623.60M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| LMAT | LeMaitre Vascular | $193.48M | $55.85M |
| UTMD | Utah Medical Products | $50.22M | $10.40M |
| PDEX | Pro-Dex | $46.09M | $14.29M |
| KRMD | KORU Medical Systems | $28.52M | $8.20M |
| ATRI | Atrion | - | $48.77M |
LMAT Revenue FAQ
What is LeMaitre Vascular’s yearly revenue?
LeMaitre Vascular's yearly revenue for 2023 was $193.48M, representing an increase of 19.69% compared to 2022. The company's yearly revenue for 2022 was $161.65M, representing an increase of 4.68% compared to 2021. LMAT's yearly revenue for 2021 was $154.42M, representing an increase of 19.37% compared to 2020.
What is LeMaitre Vascular’s quarterly revenue?
LeMaitre Vascular's quarterly revenue for Q2 2024 was $55.85M, a 4.43% increase from the previous quarter (Q1 2024), and a 11.44% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $53.48M, a 9.40% increase from the previous quarter (Q4 2023), and a 13.60% increase year-over-year (Q1 2023). LMAT's quarterly revenue for Q4 2023 was $48.88M, a 3.10% increase from the previous quarter (Q3 2023), and a 19.36% increase year-over-year (Q4 2022).
What is LeMaitre Vascular’s revenue growth rate?
LeMaitre Vascular's revenue growth rate for the last 3 years (2021-2023) was 25.29%, and for the last 5 years (2019-2023) was 65.04%.